Summary:
Study exploring the therapeutic value of an investigational medicine in patients who have not previously undergone therapy for Hepatitis C.
Qualified Participants Must:
Have Hepatitis C
Not have previously undergone therapy for Hepatitis C
Be willing to participate in a 48-week research study